Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Download in electronic PDF format for $75
Abstract: A high-performance liquid chromatographic assay method was developed to facilitate stability studies of extemporaneously compounded oral liquid formulations of ziprasidone. The method is simple and precise within the needs of the pharmaceutical profession. The throughput time is approximately 7 minutes per sample. The method is easily adaptable for individual needs.
Related Keywords:
ziprasidone mesylate, psychotropic agent, sedation, sedative, agitation, stability, assay
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Parish Roy C
|
Nov/Dec 2009
Pg. 572-573
|
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 509
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Shank Brandon R, Ofner Clyde M III
|
May/Jun 2009
Pg. 254-258
|
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Mason Dave
|
Jul/Aug 2002
Pg. 255-256
|
Assaying Progesterone in Extemporaneously Prepared Suppositories
Al-Achi Antoine, Webster Kathy, Greenwood Robert, Nicol Scott
|
Sep/Oct 1997
Pg. 339
|
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 410
|
Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 251
|
Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 498
|
Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 69
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
|
Mar/Apr 2017
Pg. 164-170
|
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 144
|
Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 503
|
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O, Zdoryk Oleksandr A
|
May/Jun 2018
Pg. 240-246
|
Fenoldopam Mesylate Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 340
|
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
|
Jan/Feb 2019
Pg. 62-64
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
| Return to Top |
